BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10468865)

  • 1. Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantation.
    Balduini CL; Noris P; Giorgiani G; Martinetti M; Klersy C; Spedini P; Belletti S; MacCario R; Gusberti L; Locatelli F
    Br J Haematol; 1999 Sep; 106(3):723-9. PubMed ID: 10468865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor.
    Balduini CL; Frassoni F; Noris P; Klersy C; Iannone AM; Bacigalupo A; Giorgiani G; Di Pumpo M; Locatelli F
    Br J Haematol; 2001 Sep; 114(4):951-3. PubMed ID: 11564091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD31 mismatching affects marrow transplantation outcome.
    Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
    Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: a retrospective analysis.
    Kögler G; Middleton PG; Wilke M; Rocha V; Esendam B; Enczmann J; Wernet P; Gluckman E; Querol S; Lecchi L; Goulmy E; Dickinson AM
    Transplantation; 2002 Oct; 74(8):1167-75. PubMed ID: 12438965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
    El-Chennawi FA; Kamel HA; Mosaad YM; El-Sherbini SM; El-Billey NA
    Hematology; 2006 Aug; 11(4):227-34. PubMed ID: 17178660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants.
    Maruya E; Saji H; Seki S; Fujii Y; Kato K; Kai S; Hiraoka A; Kawa K; Hoshi Y; Ito K; Yokoyama S; Juji T
    Blood; 1998 Sep; 92(6):2169-76. PubMed ID: 9731077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of susceptibility and protective loci for acute GVHD in unrelated HLA-matched bone marrow transplantation donors and recipients using 155 microsatellite markers on chromosome 22.
    Kikuchi T; Naruse TK; Onizuka M; Li S; Kimura T; Oka A; Morishima Y; Kulski JK; Ichimiya S; Sato N; Inoko H
    Immunogenetics; 2007 Feb; 59(2):99-108. PubMed ID: 17200870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?
    Rozman P; Karas M; Kosir A; Labar B; Madrigal A; Middleton D; Navarrete C; Oudshoorn M; Schennach H; Vitek A; Bohinjec M;
    Bone Marrow Transplant; 2003 Mar; 31(6):497-506. PubMed ID: 12665847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Segall M; Noreen H; Edwins L; Haake R; Shu XO; Kersey J
    Hum Immunol; 1996 Aug; 49(1):49-55. PubMed ID: 8839775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
    Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
    Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor histocompatibility antigen HA-1 and HPA-5 polymorphisms in HLA-identical related bone marrow transplantation.
    Kotzampasaki EM; Spyropoulou-Vlachou MS; Kalofoutis C; Vrani V; Kalofoutis A; Stavropoulos-Giokas C
    Transplant Proc; 2004; 36(6):1735-8. PubMed ID: 15350465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
    Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
    N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha gene polymorphisms are associated with severity of acute graft-versus-host disease following matched unrelated donor bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium study.
    Goyal RK; Lin Y; Schultz KR; Ferrell RE; Kim Y; Fairfull L; Livote E; Yanik G; Atlas M
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):927-936.e1. PubMed ID: 20100586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors.
    Heinemann FM; Ferencik S; Ottinger HD; Beelen DW; Grosse-Wilde H
    Transplantation; 2004 Apr; 77(7):1103-6. PubMed ID: 15087780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recipient mHag-HA1 disparity and aGVHD in thalassemic-transplanted patients.
    Nesci S; Buffi O; Iliescu A; Andreani M; Lucarelli G
    Bone Marrow Transplant; 2003 Apr; 31(7):575-8. PubMed ID: 12692624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
    van der Meer A; Allebes WA; Voorter CE; van den Berg-Loonen EM; Schattenberg AV; de Witte TJ; Joosten I
    Bone Marrow Transplant; 1998 Dec; 22(11):1049-55. PubMed ID: 9877266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease.
    Behar E; Chao NJ; Hiraki DD; Krishnaswamy S; Brown BW; Zehnder JL; Grumet FC
    N Engl J Med; 1996 Feb; 334(5):286-91. PubMed ID: 8532023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.